Homogeneity and stability evaluation of EQA serum samples for Chikungunya IgM ELISA
Аннотация
Chikungunya, a mosquito-borne viral disease caused by Chikungunya virus (CHIKV), infects humans through the bite of Aedes sp. mosquitoes, causing high fever. Diagnosis includes the detection of IgM antibodies against CHIKV by ELISA. Department of Health Research (DHR)—Indian Council of Medical Research (ICMR) implemented an External Quality Assurance Scheme (EQAS) through Proficiency Testing (PT) to ensure the accuracy and reliability of CHIKV-IgM-ELISA testing across a network of laboratories in India. The geographical distribution of the participant laboratories from the PT provider (PTP) can lead to delayed transportation while distributing the PT panels, which could result in disqualification of PT panels due to suspected sample degradation and thus necessitates expensive panel redistributions. This study evaluated panel quality by assessing homogeneity and stability across various temperatures and time periods that simulate real-world transit conditions. The results were analyzed in accordance with ISO 13528:2022. This study shows that the CHIKV-positive samples in the PT panel remained robust across all tested temperature ranges and time periods, maintaining 100% qualitative concordance for up to 168 h and at a maximum temperature of 45 °C. Therefore, we conclude that the PT panels sent for EQA for the qualitative Chikungunya IgM ELISA test will be suitable for testing at the participant laboratories when received within a time duration of 168 h with a maximum transit temperature of 45 °C. Thus, the rejection of panels due to suspected sample degradation and expensive panel redistribution can be avoided.